22468 Results

People

  1. Ladanyi
    Ladanyi
  2. Antonescu
    Antonescu
  3. Offit
    Offit
  4. Solit
    Solit
  5. Levine
    Levine
  6. Berger
    Berger
  7. O'Reilly
    O'Reilly
  8. Cheung
    Cheung
  9. Reis-Filho
    Reis-Filho
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)
  7. Human Oncology and Pathogenesis Program (5697)
  8. Center for Hematologic Malignancies (5359)
  9. Center for Molecular Imaging and Biotechnology (5298)
  10. Department of Pathology and Laboratory Medicine (4773)
  1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Overall survival at 4 years of follow-up in a phase III trial of nivolumab plus ipilimumab combination therapy in advanced melanoma (CheckMate 067)
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Rutkowski, P.; Cowey, C. L.; Lao, C.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Comparing metastatic (M) young onset (YO) colorectal cancer (CRC) with average onset (AO): Do they differ clinically and genetically?
    Meeting Abstract

    Dos Santos Fernandes, G.; Chatila, W.; Yaeger, R.; Mendelsohn, R.; Stadler, Z.; Segal, N. H.; Varghese, A.; Reidy, D.; Diaz, L.; Shia, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV(+)LMS)
    Meeting Abstract

    Kurlander, L. S.; Srinivasan, A.; Ghobadi, A.; Suser, S.; Doubrovina, E.; Boulad, F.; Mascarenhas, L.; Laquaglia, M.; Price, A.; Behr, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients
    Meeting Abstract

    Rudin, C. M.; Pandha, H. S.; Gupta, S.; Zibelman, M. R.; Akerley, W.; Day, D.; Hill, A. G.; Sanborn, R. E.; O'Day, S. J.; Clay, T. D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Initial results of phase I study of DCC-2618, a broad-spectrum KIT and PDGFRa inhibitor, in patients (pts) with gastrointestinal stromal tumor (GIST) by number of prior regimens
    Meeting Abstract

    George, S.; Heinrich, M.; Chi, P.; Razak, A.; von Mehren, M.; Gordon, M.; Ganjoo, K. N.; Somaiah, N.; Trent, J. C.; Rodon Ahnert, J.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors
    Meeting Abstract

    Boudot, A.; Huang, X.; Murphy, S.; Appleman, V.; Xu, H.; Cheung, N. K.; Macbeath, G.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Mismatch repair deficient rectal cancer is resistant to induction combination chemotherapy
    Meeting Abstract

    Cercek, A.; Dos Santos Fernandes, G.; Roxburgh, C.; Ng, S.; Yaeger, R.; Segal, N.; Ganesh, K.; Reidy, D.; Smith, J. J.; Nash, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations
    Journal Article

    Hauser, K.; Negron, C.; Albanese, S. K.; Ray, S.; Steinbrecher, T.; Abel, R.; Chodera, J. D.; Wang, L.
    Communications Biology (2018)

    Fulltext@MSK | Save